These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31356611)

  • 1. Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
    Covés-Datson EM; Dyall J; DeWald LE; King SR; Dube D; Legendre M; Nelson E; Drews KC; Gross R; Gerhardt DM; Torzewski L; Postnikova E; Liang JY; Ban B; Shetty J; Hensley LE; Jahrling PB; Olinger GG; White JM; Markovitz DM
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007595. PubMed ID: 31356611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted disruption of pi-pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity.
    Covés-Datson EM; King SR; Legendre M; Swanson MD; Gupta A; Claes S; Meagher JL; Boonen A; Zhang L; Kalveram B; Raglow Z; Freiberg AN; Prichard M; Stuckey JA; Schols D; Markovitz DM
    Sci Rep; 2021 Jan; 11(1):656. PubMed ID: 33436903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H84T BanLec has broad spectrum antiviral activity against human herpesviruses in cells, skin, and mice.
    Lloyd MG; Liu D; Legendre M; Markovitz DM; Moffat JF
    Sci Rep; 2022 Jan; 12(1):1641. PubMed ID: 35102178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 5. A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo.
    Covés-Datson EM; King SR; Legendre M; Gupta A; Chan SM; Gitlin E; Kulkarni VV; Pantaleón García J; Smee DF; Lipka E; Evans SE; Tarbet EB; Ono A; Markovitz DM
    Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2122-2132. PubMed ID: 31932446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection.
    Christodoulou I; Rahnama R; Ravich JW; Seo J; Zolov SN; Marple AN; Markovitz DM; Bonifant CL
    Front Immunol; 2021; 12():763460. PubMed ID: 35003077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications.
    Nelson EA; Barnes AB; Wiehle RD; Fontenot GK; Hoenen T; White JM
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27490565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo.
    Chan JF; Oh YJ; Yuan S; Chu H; Yeung ML; Canena D; Chan CC; Poon VK; Chan CC; Zhang AJ; Cai JP; Ye ZW; Wen L; Yuen TT; Chik KK; Shuai H; Wang Y; Hou Y; Luo C; Chan WM; Qin Z; Sit KY; Au WK; Legendre M; Zhu R; Hain L; Seferovic H; Tampé R; To KK; Chan KH; Thomas DG; Klausberger M; Xu C; Moon JJ; Stadlmann J; Penninger JM; Oostenbrink C; Hinterdorfer P; Yuen KY; Markovitz DM
    Cell Rep Med; 2022 Oct; 3(10):100774. PubMed ID: 36195094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
    Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
    Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S
    Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.
    Dhama K; Karthik K; Khandia R; Chakraborty S; Munjal A; Latheef SK; Kumar D; Ramakrishnan MA; Malik YS; Singh R; Malik SVS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():1803. PubMed ID: 30147687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
    Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.
    Shrivastava-Ranjan P; Flint M; Bergeron É; McElroy AK; Chatterjee P; Albariño CG; Nichol ST; Spiropoulou CF
    mBio; 2018 May; 9(3):. PubMed ID: 29717011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys.
    Lingemann M; Liu X; Surman S; Liang B; Herbert R; Hackenberg AD; Buchholz UJ; Collins PL; Munir S
    J Virol; 2017 May; 91(10):. PubMed ID: 28250127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
    Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis.
    McMullan LK; Flint M; Chakrabarti A; Guerrero L; Lo MK; Porter D; Nichol ST; Spiropoulou CF; Albariño C
    Lancet Infect Dis; 2019 Sep; 19(9):1023-1032. PubMed ID: 31300330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.
    Warren TK; Jordan R; Lo MK; Ray AS; Mackman RL; Soloveva V; Siegel D; Perron M; Bannister R; Hui HC; Larson N; Strickley R; Wells J; Stuthman KS; Van Tongeren SA; Garza NL; Donnelly G; Shurtleff AC; Retterer CJ; Gharaibeh D; Zamani R; Kenny T; Eaton BP; Grimes E; Welch LS; Gomba L; Wilhelmsen CL; Nichols DK; Nuss JE; Nagle ER; Kugelman JR; Palacios G; Doerffler E; Neville S; Carra E; Clarke MO; Zhang L; Lew W; Ross B; Wang Q; Chun K; Wolfe L; Babusis D; Park Y; Stray KM; Trancheva I; Feng JY; Barauskas O; Xu Y; Wong P; Braun MR; Flint M; McMullan LK; Chen SS; Fearns R; Swaminathan S; Mayers DL; Spiropoulou CF; Lee WA; Nichol ST; Cihlar T; Bavari S
    Nature; 2016 Mar; 531(7594):381-5. PubMed ID: 26934220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976.
    Hofmann-Winkler H; Gnirß K; Wrensch F; Pöhlmann S
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S172-80. PubMed ID: 25840443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.